Dr Bond and Dr Lau stated that hormone therapy may be appropriate when a woman is younger than 60 years or within 10 years of menopause. “In addition, she should have moderate to severe symptoms that ...

Precardioversion monitoring with smartphone photoplethysmography reduces same-day cardioversion cancellations for patients with AF.

Researchers compared the safety and efficacy profiles of oral P2Y12 inhibitors among patients receiving percutaneous coronary intervention.

Cannabis beverages are increasingly turning up in stores next to other beverages, and doctors warn the easy access is putting kids at risk.

Social prescribing, which connects people with support activities, may help adolescents waiting for specialist mental health services.

Blood-based biomarkers (BBM) for Alzheimer disease (AD) improve accuracy of diagnosis, according to a study presented at the annual Alzheimer’s Association In ...

Kalshi and AppliedXL launch a pilot prediction market for late-stage clinical trial outcomes and FDA decisions using objective public data sources.

The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.

The AHA released a scientific statement on tailored exercise training for patients with high-risk cardiovascular conditions.

Finerenone plus empagliflozin combination therapy reduces systolic blood pressure in patients with T2D and chronic kidney disease.

Center volume for fetal aortic valvuloplasty is not associated with technical success or complications but is linked to lower periprocedural death.

Patients with continuous public insurance or frequent coverage changes face higher mortality and graft failure risk after heart transplantation.